Neoadjuvant Chemotherapy and Tilelizumab in Stage III（cTNM-IIIA.IIIB）Non-small-cell Lung Cancer
Clinical trial NCT04865705 · UNKNOWN
Trial details
- NCT number
- NCT04865705
- Sponsor
- West China Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-10
- Primary completion
- 2021-12-10
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.